Literature DB >> 10674962

Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva.

D Sakellari1, J M Goodson, A Kolokotronis, A Konstantinidis.   

Abstract

BACKGROUND: Systemically-administered tetracyclines have been used widely for treatment of periodontal diseases with little understanding of their delivery characteristics to periodontal tissues. This study was designed to measure concentrations of 3 tetracyclines in gingival crevice fluid (GCF), plasma and saliva of following systemic administration.
METHOD: The concentration of tetracycline (TC), minocycline (MN) and doxycycline (DX) was measured in gingival crevice fluid (GCF), plasma and saliva of 20 subjects following single sequential standard oral systemic doses. Gingival crevice fluid concentration was measured at 4 sites (2 shallow and 2 deep) before administration, and at 1 h and 2 h following administration. Plasma and saliva concentrations were measured from in samples at the same time points. No antibacterial activity was detected before administration. The highest concentrations were measured 2 h after administration.
RESULTS: The average concentrations at 2 h were highest in plasma (TC = 1.02, MN=2.18, DX=2.35 microg/ml). Intermediate concentrations were measured in GCF (TC=0.61, MN= 1.49, DX= 1.65 microg/ml). Saliva concentrations (TC=0.09 MN=0.31, DX=0.47 microg/ml) were the lowest of the 3 fluids monitored. Data are presented indicating that the average GCF concentration of systemically administered tetracyclines is less than the that of plasma concentration. The concentration of tetracyclines in GCF was strongly associated with plasma concentration, indicating a primary role of drug absorption in the delivery of these systemically administered antibiotics to the site of action in periodontal therapy. The average GCF concentration in individuals varied widely (between 0 and 8 microg/ml) with approximately 50% of samples not achieving levels of 1 microg/ml.
CONCLUSION: These observations suggest that poor absorption of orally-administered tetracyclines in many individuals may account for much of the variability in clinical response to antibiotics observed in practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674962     DOI: 10.1034/j.1600-051x.2000.027001053.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  17 in total

1.  Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.

Authors:  Q Yang; R J Nakkula; J D Walters
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

2.  Characterization of eight different tetracyclines: advances in fluorescence bone labeling.

Authors:  Christoph Pautke; Stephan Vogt; Kilian Kreutzer; Cornelia Haczek; Gabriele Wexel; Andreas Kolk; Andreas B Imhoff; Horst Zitzelsberger; Stefan Milz; Thomas Tischer
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

3.  Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells.

Authors:  Gregory L Szeto; Angela K Brice; Hung-Chih Yang; Sheila A Barber; Robert F Siliciano; Janice E Clements
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

4.  Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid.

Authors:  Maria Lavda; C Esther Clausnitzer; John D Walters
Journal:  J Periodontol       Date:  2004-12       Impact factor: 6.993

5.  Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.

Authors:  Julia Cazalis; Shin-ichi Tanabe; Guy Gagnon; Timo Sorsa; Daniel Grenier
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

6.  Novel insights into the molecular events linking to cell death induced by tetracycline in the amitochondriate protozoan Trichomonas vaginalis.

Authors:  Kuo-Yang Huang; Fu-Man Ku; Wei-Hung Cheng; Chi-Ching Lee; Po-Jung Huang; Lichieh Julie Chu; Chih-Chieh Cheng; Yi-Kai Fang; Hsueh-Hsia Wu; Petrus Tang
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

7.  [Effects of inhibitory concentration minocycline on the proliferation, differentiation, and mineralization of osteoblasts].

Authors:  Hua-Ying Shao; Yi-Gong Zhang; Xue Yang; Qiong-Yue Zhang; Xiao-Hong Wu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

Review 8.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

9.  Antibacterial, anti-inflammatory, and bone-regenerative dual-drug-loaded calcium phosphate nanocarriers-in vitro and in vivo studies.

Authors:  K Madhumathi; Y Rubaiya; Mukesh Doble; R Venkateswari; T S Sampath Kumar
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

10.  Systemic anti-microbial agents used in periodontal therapy.

Authors:  Vishakha Patil; Rohini Mali; Amita Mali
Journal:  J Indian Soc Periodontol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.